학술논문

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: A phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
Document Type
Article
Source
In: Annals of the Rheumatic Diseases. (Annals of the Rheumatic Diseases, August 2008, 67(8):1096-1103)
Subject
Language
English
ISSN
00034967